Thermo Fisher Scientific acquires Dionex

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has successfully completed its acquisition of Dionex Corporation (NASDAQ: DNEX) through a short-form merger.

Pursuant to the terms of the merger, all outstanding Dionex shares (other than those held by Thermo Fisher, Dionex or any wholly owned subsidiary of Dionex, and any shareholders who validly exercised their appraisal rights in connection with the merger) will be exchanged for $118.50 per share in cash.

Source:

 Thermo Fisher Scientific

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Thermo Fisher Scientific Inc.. (2019, June 19). Thermo Fisher Scientific acquires Dionex. News-Medical. Retrieved on October 21, 2019 from https://www.news-medical.net/news/20110518/Thermo-Fisher-Scientific-acquires-Dionex.aspx.

  • MLA

    Thermo Fisher Scientific Inc.. "Thermo Fisher Scientific acquires Dionex". News-Medical. 21 October 2019. <https://www.news-medical.net/news/20110518/Thermo-Fisher-Scientific-acquires-Dionex.aspx>.

  • Chicago

    Thermo Fisher Scientific Inc.. "Thermo Fisher Scientific acquires Dionex". News-Medical. https://www.news-medical.net/news/20110518/Thermo-Fisher-Scientific-acquires-Dionex.aspx. (accessed October 21, 2019).

  • Harvard

    Thermo Fisher Scientific Inc.. 2019. Thermo Fisher Scientific acquires Dionex. News-Medical, viewed 21 October 2019, https://www.news-medical.net/news/20110518/Thermo-Fisher-Scientific-acquires-Dionex.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
Thermo Fisher Scientific collaborates with CGT Catapult to create seamless cell and gene therapy supply chain